Final Programme - iuphar

FC15 Endothelium in health and disease
Wed 287 Dual ECE/NEP inhibition and ETA/B receptor antagonists: Two ways of inhibiting endogenous ET-1
effects in resistance arteries
Pieter Lemkens, (The Netherlands), J Nelissen, JGPJ Bost, BJA Janssen, PMA Schiffers, JGR De Mey
Wed 288 Impairment of both nitric oxide and endothelium-derived hyperpolarizing factor in streptozotocin-induced
diabetic small mesenteric artery
Chen Huei Leo, (Australia), J Ziogas, JL Favaloro, OL Woodman
Wed 289 7 day treatment with 3’,4’-dihydroxyflavonol prevents endothelial dysfunction in mesenteric arteries
from streptozotocin-induced diabetic rats
Chen Huei Leo, (Australia), J Ziogas, JL Favaloro, OL Woodman
Wed 290 Inhibition of cyclooxygenase activity improves endothelium-dependent relaxation in mesenteric arteries
of ovariectomized rats following chronic inhibition of nitric oxide synthase
Susan WS Leung, (PR China), MLY Chan, GSK Man, RYK Man
Wed 291 Inhibition of Ikα kinase a/b (IKKα/β) improved insulin resistance of endothelial cells induced by high
glucose in vitro
ZX Li, FH Chen, LL Liu, RX Zhan, Y Gao, SR Peng, CX Chen, Qi-Ren Huang, (PR China)
Wed 292 Characterization of the CGRP receptor antagonist telcagepant (MK0974) in human isolated coronary
arteries
Kayi Chan, (The Netherlands), L Edvinsson, S Eftekhari, R de Vries, S Kane, R Hargreaves, J Danser,
AM van den Brink
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 265